{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:27Z","timestamp":1787028447756,"version":"build-2736575974"},"reference-count":120,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["10862.01"],"award-info":[{"award-number":["10862.01"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"THE JUDITH JANE MASON &amp; HAROLD STANNETT WILLIAMS MEMORIAL FOUNDATION","award":["MASONMECFS051 and MAS2018F00026"],"award-info":[{"award-number":["MASONMECFS051 and MAS2018F00026"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neurological disorders, including neurodegenerative diseases, are collectively a major cause of death and disability worldwide. Whilst the underlying disease mechanisms remain elusive, altered mitochondrial function has been clearly implicated and is a key area of study in these disorders. Studying mitochondrial function in these disorders is difficult due to the inaccessibility of brain tissue, which is the key tissue affected in these diseases. To overcome this issue, numerous cell models have been used, each providing unique benefits and limitations. Here, we focussed on the use of lymphoblastoid cell lines (LCLs) to study mitochondrial function in neurological disorders. LCLs have long been used as tools for genomic analyses, but here we described their use in functional studies specifically in regard to mitochondrial function. These models have enabled characterisation of the underlying mitochondrial defect, identification of altered signalling pathways and proteins, differences in mitochondrial function between subsets of particular disorders and identification of biomarkers of the disease. The examples provided here suggest that these cells will be useful for development of diagnostic tests (which in most cases do not exist), identification of drug targets and testing of pharmacological agents, and are a worthwhile model for studying mitochondrial function in neurological disorders.<\/jats:p>","DOI":"10.3390\/ijms22094536","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T02:31:43Z","timestamp":1619490703000},"page":"4536","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-3985","authenticated-orcid":false,"given":"Sarah Jane","family":"Annesley","sequence":"first","affiliation":[{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-6306","authenticated-orcid":false,"given":"Paul Robert","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbagen.2013.10.019","article-title":"Dictyostelium, a microbial model for brain disease","volume":"1840","author":"Annesley","year":"2014","journal-title":"BBA-Gen. Subj."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1387\/ijdb.190233pf","article-title":"The Dictyostelium model for mitochondrial biology and disease","volume":"63","author":"Pearce","year":"2019","journal-title":"Int. J. Dev. Biol."},{"key":"ref_3","first-page":"14","article-title":"Yeast as a model for studying human neurodegenerative disorders","volume":"3","author":"Giorfini","year":"2008","journal-title":"Biotechnol. J."},{"key":"ref_4","first-page":"28","article-title":"Fly Models of Human Diseases: Drosophila as a Model for Understanding Human Mito-chondrial Mutations and Disease","volume":"121","author":"Sen","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_5","first-page":"17","article-title":"Mitochondrial diseases and the role of the yeast models","volume":"10","author":"Ferrero","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bolus, H., Crocker, K., Boekhoff-Falk, G., and Chtarbanova, S. (2020). Modeling Neurodegenerative Disorders in Drosophila melanogaster. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093055"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Caldwell, K.A., Willicott, C.W., and Caldwell, G.A. (2020). Modeling neurodegeneration in Caenorhabditis elegans. Dis. Models Mech.","DOI":"10.1242\/dmm.046110"},{"key":"ref_8","first-page":"15","article-title":"The role of mitochondria in the life of the nematode, Caenorhabditis elegans","volume":"1638","author":"Tsang","year":"2003","journal-title":"BBA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neurobiolaging.2006.06.021","article-title":"Is aging part of Alzheimer\u2019s disease, or is Alzheimer\u2019s disease part of aging?","volume":"28","author":"Swerdlow","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_10","first-page":"13","article-title":"Gene expression profiling in human neurodegenerative disease","volume":"9","author":"Kirby","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pinho, R., Guedes, L.C., Soreq, L., Lobo, P.P., Mestre, T., Coelho, M., Rosa, M.M., Gon\u00e7alves, N., Wales, P., and Mendes, T. (2017). Gene Expression Differences in Peripheral Blood of Parkinson\u2019s Disease Patients with Distinct Pro-gression Profiles. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0190552"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Soreq, L., Guffanti, A., Salomonis, N., Simchovitz, A., Israel, Z., Bergman, H., and Soreq, H. (2014). Long non-coding RNA and alternative splicing modulations in Parkinson\u2019s leukocytes identified by RNA sequencing. PLoS Comput. Biol., 10.","DOI":"10.1371\/journal.pcbi.1003517"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1582-4934.2011.01444.x","article-title":"Deep brain stimulation induces rapidly reversible transcript changes in Parkinson\u2019s leucocytes","volume":"16","author":"Soreq","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G., and Zhu, X. (2020). Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances. Mol. Neurodegener., 15.","DOI":"10.1186\/s13024-020-00376-6"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_16","first-page":"25","article-title":"Mitochondrial Dysfunction in Huntington\u2019s Disease","volume":"1049","author":"Carmo","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165918","DOI":"10.1016\/j.bbadis.2020.165918","article-title":"The emerging molecular mechanisms for mitochondrial dysfunctions in FXTAS","volume":"1866","author":"Gohela","year":"2020","journal-title":"BBA-Mol. Basis Dis."},{"key":"ref_18","first-page":"2","article-title":"Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium","volume":"12","author":"Gey","year":"1952","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1074\/jbc.M508786200","article-title":"HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin","volume":"280","author":"Iwata","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41587-019-0037-y","article-title":"Multi-omic measurements of heterogeneity in HeLa cells across laboratories","volume":"37","author":"Liu","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/hmg\/9.18.2683","article-title":"Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity","volume":"9","author":"Tabrizi","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson\u2019s disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4137\/JEN.S25100","article-title":"A simple model to study tau pathology","volume":"10","author":"Houck","year":"2016","journal-title":"J. Exp. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000078556","article-title":"Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches","volume":"106","author":"Bylund","year":"2004","journal-title":"Cytogenet. Genome Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5767","article-title":"Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations","volume":"5","author":"Lin","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_28","first-page":"7","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Xicoy, H., Wieringa, B., and Martens, G.J.M. (2017). The SH-SY5Y cell line in Parkinson\u2019s disease research: A systematic review. Mol. Neurodegener., 12.","DOI":"10.1186\/s13024-017-0149-0"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ferrari, E., Cardinale, A., Picconib, B., and Gardoni, F. (2020). From cell lines to pluripotent stem cells for modelling Parkinson\u2019s Disease. J. Neurosci. Methods, 340.","DOI":"10.1016\/j.jneumeth.2020.108741"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wiatrak, B., Kubis-Kubiak, A., Piwowar, A., and Barg, E. (2020). PC12 Cell Line: Cell Types, Coating of Culture Vessels, Differentiation and Other Culture Conditions. Cells, 9.","DOI":"10.3390\/cells9040958"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.redox.2017.04.003","article-title":"Artemisinin protects PC12 cells against \u03b2-amyloid-induced apoptosis through activation of the ERK1\/2 signaling pathway","volume":"12","author":"Zeng","year":"2017","journal-title":"Redox Biol."},{"key":"ref_34","first-page":"17","article-title":"Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells","volume":"20","author":"Zhang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Krishna, A., Biryukov, M., Trefois, C., A Antony, P.M., Hussong, R., Lin, J., Hein\u00e4niemi, M., Glusman, G., Koeglsberger, S., and Boyd, O. (2014). Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson\u2019s disease. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-1154"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","article-title":"Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway","volume":"25","author":"Lotharius","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-4159.2011.07255.x","article-title":"Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line","volume":"119","author":"Scholz","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_38","first-page":"7","article-title":"The disparity between human cell senescence in vitro and lifelong replication in vivo","volume":"20","author":"Ruben","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10616-014-9771-7","article-title":"Fibroblast sources: Where can we get them?","volume":"68","author":"Fernandes","year":"2016","journal-title":"Cytotechnology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1126\/science.622567","article-title":"Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors","volume":"199","author":"Goldstein","year":"1978","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/gerona\/57.7.B251","article-title":"Cellular Senescence and Tissue Aging In Vivo","volume":"57","author":"Hornsby","year":"2002","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1083\/jcb.141.2.515","article-title":"Integrin and Cadherin Synergy Regulates Contact Inhibition of Migration and Motile Activity","volume":"141","author":"Huttenlocher","year":"1998","journal-title":"J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1039\/D0AY02040K","article-title":"Comparison of sample preparation methodologies towards optimisation of Raman spectroscopy for peripheral blood mononuclear cells","volume":"13","author":"Chaudhary","year":"2021","journal-title":"Anal. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Missailidis, D., Annesley, S.J., Allan, C.Y., Sanislav, O., Lidbury, B.A., Lewis, D.P., and Fisher, P.R. (2020). An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME\/CFS Patients. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints201909.0043.v3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2008.04.004","article-title":"Parkinson patient fibroblasts show increased alpha-synuclein expression","volume":"212","author":"Hoepken","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"ref_47","unstructured":"Percy, M.E., Andrews, D., and Potter, H. (2000). Peripheral Markers of Alzheimer\u2019s Disease, Directions From the Alzheimer Pathogenic Pathway, Human Press."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Raffaele, S., Boccazzi, M., and Fumagalli, M. (2021). Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives. Cells, 10.","DOI":"10.3390\/cells10030565"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Edwards, G., Gamez, N., Armijo, E., Kramm, C., Morales, R., Taylor-Presse, K., Schulz, P.E., Soto, C., and Moreno-Gonzalez, I. (2019). Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson\u2019s Disease-Associated Pathology. Cells, 8.","DOI":"10.3390\/cells8111359"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41467-019-13830-x","article-title":"Genetic aberrations in iPSCs are introduced by a transient G1\/S cell cycle checkpoint deficiency","volume":"11","author":"Araki","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19710","DOI":"10.1038\/s41598-020-76705-y","article-title":"Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs","volume":"10","author":"Cevallos","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Houldcroft, C.J., Petrova, V., Liu, J.Z., Frampton, D., Anderson, C.A., Gall, A., and Kellam, P. (2014). Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108384"},{"key":"ref_55","unstructured":"Longnecker, R.M., Kieff, E., and Cohen, J.I. (2013). Epstein-Barr Virus, Lippincott, Wilkins, and Williams. [6th ed.]."},{"key":"ref_56","first-page":"75","article-title":"Lymphoblastoid Cell lines: A Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair","volume":"1","author":"Hussain","year":"2012","journal-title":"Int. J. Mol. Cell. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbagen.2003.10.014","article-title":"Genetic instability in EBV-transformed lymphoblastoid cell lines","volume":"1670","author":"Mohyuddin","year":"2004","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/hmg\/ddr041","article-title":"The effects of EBV transformation on gene expression levels and methylation profiles","volume":"21","author":"Caliskan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Missailidis, D., Sanislav, O., Allan, C.Y., Smith, P.K., Annesley, S.J., and Fisher, P.R. (2021). Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME\/CFS Lymphoblasts. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042046"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02533-3","article-title":"SWATH-MS analysis of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction","volume":"18","author":"Sweetman","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0304-3940(98)00741-1","article-title":"Fibroblasts from Alzheimer\u2019s disease donors do not differ from controls in response to heat shock","volume":"256","author":"Arosio","year":"1998","journal-title":"Neurosci. Lett."},{"key":"ref_62","first-page":"11","article-title":"Epigenetic mechanisms in the development of memory and their involvement in certain neurological diseases","volume":"31","year":"2016","journal-title":"Neurology"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Loke, Y.J., Hannan, A.J., and Craig, J.M. (2015). The Role of Epigenetic Change in Autism Spectrum Disorders. Front. Neurol., 6.","DOI":"10.3389\/fneur.2015.00107"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jnr.22000","article-title":"Utility of lymphoblastoid cell lines","volume":"87","author":"Sie","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jnc.14820","article-title":"Role of the endolysosomal system in Parkinson\u2019s disease","volume":"150","author":"Vidyadhara","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4809","article-title":"The genetics and pathology of mitochondrial disease","volume":"241","author":"Alston","year":"2017","journal-title":"J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson\u2019s disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s Disease: Mechanisms and Models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1242\/dmm.025684","article-title":"Immortalized Parkinson\u2019s disease lymphocytes have enhanced mitochondrial respiratory activity","volume":"9","author":"Annesley","year":"2016","journal-title":"Dis. Models Mech."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"dmm040899","DOI":"10.1242\/dmm.040899","article-title":"Misfolded alpha-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells","volume":"13","author":"Ugalde","year":"2020","journal-title":"Dis. Models Mech."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Fernando, S., Allan, C.Y., Mroczek, K., Pearce, X., Sanislav, O., Fisher, P.R., and Annesley, S.J. (2020). Cytotoxicity and Mitochondrial Dysregulation Caused by \u03b1-Synuclein in Dictyostelium discoideum. Cells, 9.","DOI":"10.3390\/cells9102289"},{"key":"ref_75","first-page":"1261","article-title":"The Parkinson\u2019s disease-associated protein DJ-1 plays a positive nonmitochondrial role in endocytosis in Dictyostelium cells","volume":"10","author":"Chen","year":"2017","journal-title":"Dis. Models Mech."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Haylett, W.S.C., van der Westhuizen, F., van Dyk, H., van der Merwe, L., van der Merwe, C., Loos, B., Carr, J., Kinnear, C., and Bardien, S. (2016). Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson\u2019s Disease Patients. Parkinsons Dis.","DOI":"10.1155\/2016\/1819209"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.301.6763.1256","article-title":"Increased energy expenditure in Parkinson\u2019s disease","volume":"301","author":"Levi","year":"1990","journal-title":"BMJ"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Klein, C.W.A. (2012). Genetics of Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med., 2.","DOI":"10.1101\/cshperspect.a008888"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"17293","DOI":"10.1038\/s41598-020-74195-6","article-title":"Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson\u2019s disease","volume":"10","author":"Toste","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/hmg\/ddx320","article-title":"LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson\u2019s disease","volume":"26","author":"Howlett","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Chia, S.J., Tan, E.-K., and Chao, Y.X.I. (2020). Historical Perspective: Models of Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072464"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00702-009-0328-4","article-title":"Abnormal morphology of peripheral cell tissues from patients with Huntington disease. Abnormal morphology of peripheral cell tissues from patients with Huntington disease","volume":"117","author":"Squitieri","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12035-014-8735-4","article-title":"Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s Disease human lymphoblasts","volume":"51","author":"Naia","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/pr500649m","article-title":"Proteomics of Huntington\u2019s disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances","volume":"13","author":"McQuade","year":"2014","journal-title":"J. Proteome Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11745-015-4110-0","article-title":"Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly","volume":"51","author":"Mejia","year":"2016","journal-title":"Lipids"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-4159.2006.03998.x","article-title":"Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington\u2019s disease","volume":"98","author":"Mormone","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mad.2005.09.011","article-title":"Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington\u2019s disease mutation","volume":"127","author":"Maglione","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_94","unstructured":"Pansarasa, O., Bordoni, M., Drufuca, L., Diamanti, L., Sproviero, D., Trotti, R., Bernuzzi, S., La Salvia, S., Gagliardi, S., and Ceroni, M. (2018). Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis. Models Mech., 11."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"a024125","DOI":"10.1101\/cshperspect.a024125","article-title":"Genetics of Amyotrophic Lateral Sclerosis","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1073\/pnas.1115402109","article-title":"An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1","volume":"109","author":"Guareschi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1074\/jbc.M006476200","article-title":"Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber\u2019s hereditary optic neuropathy mitochondrial DNA mutation","volume":"275","author":"Brown","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ranieri, M., Brajkovic, S., Riboldi, G., Ronchi, D., Rizzo, F., Bresolin, N., Corti, S., and Comi, G.P. (2013). Mitochondrial Fusion Proteins and Human Diseases. Neurol. Res. Int.","DOI":"10.1155\/2013\/293893"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng0593-47","article-title":"Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31","volume":"4","author":"Sheffield","year":"1993","journal-title":"Nat. Genet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1126\/science.1066901","article-title":"Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin","volume":"295","author":"Rezaie","year":"2002","journal-title":"Science"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/eye.2011.97","article-title":"Primary open-angle glaucoma genes","volume":"25","author":"Fingert","year":"2011","journal-title":"Eye"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.12-9596","article-title":"Impaired Complex-I-Linked Respiration and ATP Synthesis in Primary Open-Angle Glaucoma Patient Lymphoblasts","volume":"53","author":"Lee","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Van Bergen, N.J., Crowston, J.G., Kearns, L.S., Staffieri, S.E., Hewitt, A.W., Cohn, A.C., Mackey, D.A., and Trounce, I.A. (2011). Mitochondrial Oxidative Phosphorylation Compensation May Preserve Vision in Patients with OPA1-Linked Autosomal Dominant Optic Atrophy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021347"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Van Bergen, N.J., Crowston, J.G., Craig, J.E., Burdon, K.P., Kearns, L.S., Sharma, S., Hewitt, A.W., Mackey, D.A., and Trounce, I.A. (2015). Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic Neuropathy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140919"},{"key":"ref_105","first-page":"9","article-title":"OXPHOS bioenergetic compensation does not explain disease penetrance in Leber hereditary optic neuropathy","volume":"54","author":"Sanchez","year":"2020","journal-title":"Mitochondrion"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mds.27420","article-title":"Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females","volume":"33","author":"Loesch","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-0004.2009.01275.x","article-title":"Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism","volume":"76","author":"Loesch","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.28086","article-title":"Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death","volume":"35","author":"Hall","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Todd, P.K., Krans, A., Pandey, U.B., Di Prospero, N.A., Min, K.T., Taylor, J.P., and Paulson, H.L. (2011). Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet., 6.","DOI":"10.1371\/journal.pgen.1001240"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000446803","article-title":"Novel blood biomarkers are associated with the white matter lesion in Fragile X Associated Tremor\/Ataxia Syndrome","volume":"17","author":"Loesch","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fgene.2018.00531","article-title":"The Spectrum of Neurological, Cognitive and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles are Linked to Genetic (CGG and FMR mRNA) and Cellular Stress (AMPK) Markers","volume":"9","author":"Trost","year":"2018","journal-title":"Front. Genet."},{"key":"ref_114","unstructured":"Vallings, R. (2012). Chronic Fatigue Syndrome M.E. Symptoms: Diagnosis & Management, Calico Publishing Ltd."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Tomas, C.B., Strassheim, V., Elson, J.L., Newton, J., and Manning, P. (2017). Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186802"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e6500","DOI":"10.7717\/peerj.6500","article-title":"Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types","volume":"7","author":"Tomas","year":"2019","journal-title":"PeerJ"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mito.2011.05.005","article-title":"Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome","volume":"11","author":"Smits","year":"2011","journal-title":"Mitochondrion"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1038\/tp.2016.184","article-title":"Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome","volume":"6","author":"Ciregia","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jcp.2005.025718","article-title":"Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome","volume":"58","author":"Kaushik","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Missailidis, D., Sanislav, O., Allan, C.Y., Annesley, S.J., and Fisher, P.R. (2020). Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202002.0029.v1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4536\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:05Z","timestamp":1760161985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":120,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094536"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094536","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]}}}